TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Kashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Need to reduce meditech imports, says Pharma Secy

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement
Advertisement

New Delhi, May 7

Advertisement

The government and industry must jointly work towards reducing import dependence in the meditech sector from 75 per cent to 50 per cent in the next five years, said Dr Arunish Chawla, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers.

Speaking at the launch of “The Meditech Stackathon 2024”, organised by the department in collaboration with Confederation of Indian Industry (CII), Chawla said India’s meditech industry held immense potential with projections estimating a growth rate of 28 per cent annually reaching a size of $50 billion by 2030.

“We have to be ‘aatmanirbhar’ in medical devices and reduce import dependence,” the secretary said.

Advertisement

Advertisement
Show comments
Advertisement